CTIS2024-516089-12-00进行中(未招募)1 期
Assisted reproductive technology (ART) and pregnancy outcomes in women with adenomyosis (internal endometriosis) according to stimulation protocol in relation to immunological and endometrial features: a prospective, randomized study - ADENOFERT
Azienda Ospedaliero Universitaria Di Modena0 个研究点目标入组 500 人开始时间: 2024年7月16日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64(—)
入选标准
- •Uterine adenomyosis diagnosed on ultrasound scan defined when at least ne of the following features is recognized: (1) heterogeneous myometrium; (2) hypoechoic striation in the myometrium; (3) myometrial anechoic lacunae or cysts; (4) asymmetrical myometrial thickening of the uterine walls. - Couples requiring a cycle of IVF/ICSI meeting the criteria of the Italian law to be included in an ART program. - Good physical and mental health (e.g. no contraindication to the therapeutic regimen for IVF/ICSI, like moderate or severe impairment of renal or hepatic function etc.). - First or second IVF/ICSI attempt. - Absence of severe premature ovarian insufficiency defined by antral follicle count < 8 and AMH < 1ng/ml. - The female partner is =18 and < 42 years of age. - The female partner has a BMI <30. - Both partners are willing and able to provide written informed consent.
排除标准
- •- Concurrent and/or recent involvement in other studies likely to interfere with the intervention within the previous 3 months of study enrolment. - Other potential causes of implantation failure: leiomyoma, actual hydrosalpinx, malformed uterus (unicornis, bicornis, septate, duplex), antiphospholipid syndrome - A prior history of endometrial ablation, endometrial polyps, hydrosalpinx, smocking habits, known endometriosis stage III-IV, abnormal uterine bleeding of unknown cause. - Uterine fibroids (untreated FIGO Type 0-I-II and type III-IV fibroids > 3 cm) - Use of GnRH analogues within previous 3 months. - Extreme severe male factor infertility (sperm count < 1 x 106/ml, use or surgically retrieved spermatozoa) - Positive plasma viral load for human immunodeficiency virus (HIV), hepatitis C virus (HCV) or hepatitis B virus (HBV) for one (or both) in the couple during the year before inclusion - Couples who in the opinion of the researcher would be unable to give fully informed consent to the study.
研究者
相似试验
招募中
Unknown
Assisted Reproductive Technology in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (ARTiMS) study. A prospective, longitudinal study.Pregnancysub-fertilityNeuromyelitis Optica Spectrum DisordersNeurological - Multiple sclerosisNeurological - Other neurological disordersReproductive Health and Childbirth - Fertility including in vitro fertilisationMultiple SclerosisACTRN12623001310651John Hunter Hospital of the Hunter New England Local Health District25
未知
不适用
Assisted reproductive technology using unfertilized oocytes for fertility preservation of young women in malignant diseasesMalignant diseaseJPRN-UMIN000019590Jichi Medical University40
已完成
不适用
Effect of Assisted Reproductive Technology on Cardiac Development in Childhood Assessed by EchocardiographyAssisted Reproductive TechnologyNCT02190422Nanjing Medical University200
招募中
不适用
Fertility Preservation and Assisted Reproductive TechnologyInfertility Adolescent and Young Adult Women with CancerJPRN-UMIN000032033Hyogo College of Medicine, Department of Obstetrics and Gynecology10,000
招募中
4 期
Adenomyosis and ARTAdenomyosisNCT05937490Azienda Ospedaliero-Universitaria di Modena500
